These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1149 related articles for article (PubMed ID: 21723318)
21. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice. Kassa J; Humlicek V Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512 [TBL] [Abstract][Full Text] [Related]
22. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterases. Kuca K; Cabal J; Jun D; Bajgar J; Hrabinova M J Enzyme Inhib Med Chem; 2006 Dec; 21(6):663-6. PubMed ID: 17252938 [TBL] [Abstract][Full Text] [Related]
23. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats. Kassa J; Karasova J; Vasina L J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413 [TBL] [Abstract][Full Text] [Related]
24. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317 [TBL] [Abstract][Full Text] [Related]
25. Effect of different oximes on rat and human cholinesterases inhibited by methamidophos: a comparative in vitro and in silico study. Lugokenski TH; Gubert P; Bueno DC; Nogara PA; de Aquino Saraiva R; Barcelos RP; Carratu VS; Bresolin L; de Vargas Barbosa NB; Pereira ME; da Rocha JB; Soares FA Basic Clin Pharmacol Toxicol; 2012 Dec; 111(6):362-70. PubMed ID: 22703537 [TBL] [Abstract][Full Text] [Related]
26. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing. Bartosova L; Kuca K; Jun D; Kunesova G Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932 [TBL] [Abstract][Full Text] [Related]
27. Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes. Kuca K; Jun D J Med Toxicol; 2006 Dec; 2(4):141-6. PubMed ID: 18072133 [TBL] [Abstract][Full Text] [Related]
28. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. Kassa J; Karasova J Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis. Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559 [TBL] [Abstract][Full Text] [Related]
30. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents. Renou J; Mercey G; Verdelet T; Păunescu E; Gillon E; Arboléas M; Loiodice M; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY Chem Biol Interact; 2013 Mar; 203(1):81-4. PubMed ID: 23111374 [TBL] [Abstract][Full Text] [Related]
31. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin. Kuca K; Cabal J; Jun D; Hrabinova M Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats. Stojiljković MP; Škrbić R; Jokanović M; Kilibarda V; Bokonjić D; Vulović M Toxicology; 2018 Sep; 408():113-124. PubMed ID: 30176331 [TBL] [Abstract][Full Text] [Related]
33. Potency of novel oximes to reactivate sarin inhibited human cholinesterases. Jun D; Kuca K; Picha J; Koleckar V; Marek J Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504 [TBL] [Abstract][Full Text] [Related]
34. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase. Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478 [TBL] [Abstract][Full Text] [Related]
35. Lactational exposure to malathion inhibits brain acetylcholinesterase in mice. da Silva AP; Meotti FC; Santos AR; Farina M Neurotoxicology; 2006 Dec; 27(6):1101-5. PubMed ID: 16716398 [TBL] [Abstract][Full Text] [Related]
36. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122 [TBL] [Abstract][Full Text] [Related]
37. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Kuca K; Cabal J; Kassa J Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060 [TBL] [Abstract][Full Text] [Related]